Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.10.0.1
Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Statement of Financial Position [Abstract]    
Amortized cost of securities available for sale $ 588,097 $ 581,992
Allowance for loan losses of loans receivable $ 31,676 $ 31,043
Common stock, par value (in usd per share) $ 0.001 $ 0.001
Common stock authorized (shares) 62,500,000 62,500,000
Common stock issued (shares) 33,188,833 33,083,133
Common stock outstanding (shares) 32,087,236 32,431,627
Accumulated other comprehensive loss, tax expense/(benefit) $ 4,566 $ 1,319
Treasury stock (shares) 1,101,597 651,506